These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10377159)

  • 1. The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.
    Benyacoub J; Hopkins S; Potts A; Kelly S; Kraehenbuhl JP; Curtiss R; De Grandi P; Nardelli-Haefliger D
    Infect Immun; 1999 Jul; 67(7):3674-9. PubMed ID: 10377159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.
    Nardelli-Haefliger D; Roden RB; Benyacoub J; Sahli R; Kraehenbuhl JP; Schiller JT; Lachat P; Potts A; De Grandi P
    Infect Immun; 1997 Aug; 65(8):3328-36. PubMed ID: 9234794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium.
    Baud D; Benyacoub J; Revaz V; Kok M; Ponci F; Bobst M; Curtiss R; De Grandi P; Nardelli-Haefliger D
    Infect Immun; 2004 Feb; 72(2):750-6. PubMed ID: 14742517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.
    Corthésy-Theulaz IE; Hopkins S; Bachmann D; Saldinger PF; Porta N; Haas R; Zheng-Xin Y; Meyer T; Bouzourène H; Blum AL; Kraehenbuhl JP
    Infect Immun; 1998 Feb; 66(2):581-6. PubMed ID: 9453612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
    Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
    Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
    Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
    J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.
    Krul MR; Tijhaar EJ; Kleijne JA; Van Loon AM; Nievers MG; Schipper H; Geerse L; Van der Kolk M; Steerenberg PA; Mooi FR; Den Otter W
    Cancer Immunol Immunother; 1996 Sep; 43(1):44-8. PubMed ID: 8917635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
    Ohlschläger P; Osen W; Dell K; Faath S; Garcea RL; Jochmus I; Müller M; Pawlita M; Schäfer K; Sehr P; Staib C; Sutter G; Gissmann L
    J Virol; 2003 Apr; 77(8):4635-45. PubMed ID: 12663770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar Typhimurium and its cloned antigen.
    Garcia CA; Martin M; Michalek SM
    Infect Immun; 2004 Oct; 72(10):5824-31. PubMed ID: 15385483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs.
    Kennedy MJ; Yancey RJ; Sanchez MS; Rzepkowski RA; Kelly SM; Curtiss R
    Infect Immun; 1999 Sep; 67(9):4628-36. PubMed ID: 10456909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunogenicity of a Deltacya Deltacrp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse.
    Sheoran AS; Timoney JF; Tinge SA; Sundaram P; Curtiss R
    Vaccine; 2001 May; 19(25-26):3591-9. PubMed ID: 11348727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A (SpaA) of Streptococcus sobrinus: effects of the Salmonella virulence plasmid on the induction of protective and sustained humoral responses in rats.
    Redman TK; Harmon CC; Michalek SM
    Vaccine; 1996 Jun; 14(9):868-78. PubMed ID: 8843628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.
    Echchannaoui H; Bianchi M; Baud D; Bobst M; Stehle JC; Nardelli-Haefliger D
    Infect Immun; 2008 May; 76(5):1940-51. PubMed ID: 18332214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
    Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus-like particle vaccines.
    Schiller JT; Lowy DR
    J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.